BridgeBio Pharma (BBIO) FCF Margin Growth (1y) (2020 - 2026)
BridgeBio Pharma (BBIO) FCF Margin Growth (1y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
5,389.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,525.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
BridgeBio Pharma |
12.90 Bn |
11.97 Bn |
184.58 Mn |
6,965.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
6,965.00 |
| Dec 31, 2025 |
328,424.00 |
| Sep 30, 2025 |
654,887.00 |
| Jun 30, 2025 |
-351,891.00 |
| Mar 31, 2025 |
-6,709.00 |
| Dec 31, 2024 |
385,634.00 |
| Sep 30, 2024 |
-307,119.00 |
| Jun 30, 2024 |
1.04 Mn |
| Mar 31, 2024 |
780,036.00 |
| Dec 31, 2023 |
-219,232.00 |
| Sep 30, 2023 |
3.64 Mn |
| Jun 30, 2023 |
-687,458.00 |
| Mar 31, 2023 |
162,891.00 |
| Dec 31, 2022 |
-362,125.00 |
| Sep 30, 2022 |
-3.45 Mn |
| Jun 30, 2022 |
106,565.00 |
| Mar 31, 2022 |
2.35 Mn |
| Dec 31, 2021 |
7.40 Mn |
| Sep 30, 2021 |
-383,465.00 |
| Sep 30, 2020 |
-143,840.00 |
